These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6119923)

  • 21. Oral risperidone with lorazepam versus oral zuclopenthixol with lorazepam in the treatment of acute psychosis in emergency psychiatry: a prospective, comparative, open-label study.
    Hovens JE; Dries PJ; Melman CT; Wapenaar RJ; Loonen AJ
    J Psychopharmacol; 2005 Jan; 19(1):51-7. PubMed ID: 15671129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Orofacial dyskinesias associated with lorazepam therapy.
    Sandyk R
    Clin Pharm; 1986 May; 5(5):419-21. PubMed ID: 3720213
    [No Abstract]   [Full Text] [Related]  

  • 23. Benzodiazepines in therapy.
    Cohen S
    Curr Psychiatr Ther; 1983; 22():111-7. PubMed ID: 6145545
    [No Abstract]   [Full Text] [Related]  

  • 24. Unraveling anxiety and depression.
    Mynatt S; Cunningham P
    Nurse Pract; 2007 Aug; 32(8):28-36; CEU quiz 36-7. PubMed ID: 17667764
    [No Abstract]   [Full Text] [Related]  

  • 25. Benzodiazepines for catatonic symptoms, stupor, and mutism.
    Wetzel H; Heuser I; Benkert O
    Pharmacopsychiatry; 1988 Nov; 21(6):394-5. PubMed ID: 2907648
    [No Abstract]   [Full Text] [Related]  

  • 26. [Advances in the study on depressive and anxiety disorders treated with traditional Chinese medicine and herbal drugs].
    Li JM; Kong LD
    Zhongguo Zhong Yao Za Zhi; 2001 Dec; 26(12):805-7. PubMed ID: 12834251
    [No Abstract]   [Full Text] [Related]  

  • 27. Introduction. The multiplicity of uses of benzodiazepines.
    Lapierre YD
    Can J Psychiatry; 1993 Nov; 38 Suppl 4():S101. PubMed ID: 7905779
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders.
    Lee JH; Dunner DL
    Depress Anxiety; 2008; 25(2):91-7. PubMed ID: 17311265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparison of 6 different methods for lorazepam withdrawal. A controlled study, hydroxyzine versus placebo].
    Lemoine P; Touchon J; Billardon M
    Encephale; 1997; 23(4):290-9. PubMed ID: 9417395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Introduction: treating depression and anxiety to remission.
    Schatzberg AF
    J Clin Psychiatry; 2003; 64 Suppl 15():3-4. PubMed ID: 14658983
    [No Abstract]   [Full Text] [Related]  

  • 31. Lorazepam (Ativan).
    Med Lett Drugs Ther; 1978 Mar; 20(6):31-2. PubMed ID: 24801
    [No Abstract]   [Full Text] [Related]  

  • 32. Tofizopam in the therapy of anxious-depressive syndromes.
    Molcan J; Novotny V; Korinkova V; Konikova M
    Agressologie; 1981 Nov; 22(D):23-4. PubMed ID: 6120663
    [No Abstract]   [Full Text] [Related]  

  • 33. The anxiolytic SC 48274 (AGN 2979; BTG 1501) in generalized anxiety disorder.
    Gittos MW
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Dec; 18(8):i-ii. PubMed ID: 7863012
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of Lorazepam on emotional status and quality of life of patients with ischemic heart disease].
    Ibatov AD
    Kardiologiia; 2006; 46(9):11-4. PubMed ID: 17047616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Benzodiazepine therapy: an evaluation].
    Beckmann H; Haas S
    Nervenarzt; 1984 Mar; 55(3):111-21. PubMed ID: 6144052
    [No Abstract]   [Full Text] [Related]  

  • 36. [The influence of alprazolam on the symptoms of anxiety and depression].
    Małyszczak K; Kiejna A
    Psychiatr Pol; 1997; 31(6):745-52. PubMed ID: 9515306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How to ensure clinical trial sensitivity in psychotropic drug development: a case study.
    Videla S; Sust M; Fresquet A; Villoria J
    Clin Ther; 2005 Feb; 27(2):252-4. PubMed ID: 15811489
    [No Abstract]   [Full Text] [Related]  

  • 38. Re: Lorazepam-induced prolongation of the QT interval in a patient with schizoaffective disorder and complete AV block.
    Crockford D
    Can J Psychiatry; 2005 Mar; 50(3):184-5; author reply 185. PubMed ID: 15830830
    [No Abstract]   [Full Text] [Related]  

  • 39. Anxiety and depressive disorders in college youth.
    Bhave S; Nagpal J
    Pediatr Clin North Am; 2005 Feb; 52(1):97-134, ix. PubMed ID: 15748927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Do co-existing psychosocial problems influence the prescription of psychotropic medication in depressive and anxiety disorders?
    van Rijswijk E; Lucassen P; van De Lisdonk E; Zitman F; van Weel C
    Eur J Gen Pract; 2006; 12(1):37-9. PubMed ID: 16945871
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.